BioScience Health Innovations (BHIC) Stock Overview

Operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. More details

BHIC fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($49M)

BHIC Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

BioScience Health Innovations, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioScience Health Innovations
Historical stock prices
Current Share Price	US$4.10
52 Week High	US$9.98
52 Week Low	US$0.52
Beta	1.34
1 Month Change	0.99%
3 Month Change	94.31%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-48.75%
Change since IPO	86.36%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BHIC	US Healthcare	US Market
7D	0.2%	3.4%	0.3%
1Y	n/a	19.8%	19.9%

Return vs Industry: Insufficient data to determine how BHIC performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how BHIC performed against the US Market.

Price Volatility

Is BHIC's price volatile compared to industry and market?
BHIC volatility
BHIC Average Weekly Movement	32.2%
Healthcare Industry Average Movement	7.1%
Market Average Movement	7.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: BHIC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine BHIC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Darren Lopez	biosciencehealthinnovation.com

BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and peptide delivery.

BioScience Health Innovations, Inc. Fundamentals Summary

How do BioScience Health Innovations's earnings and revenue compare to its market cap?
BHIC fundamental statistics
Market cap	US$49.42m
Earnings (TTM)	-US$14.61k
Revenue (TTM)	US$5.21m

9.0x

P/S Ratio

-3,203x

P/E Ratio

Is BHIC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BHIC income statement (TTM)
Revenue	US$5.21m
Cost of Revenue	US$2.38m
Gross Profit	US$2.83m
Other Expenses	US$2.84m
Earnings	-US$14.61k

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0013
Gross Margin	54.29%
Net Profit Margin	-0.28%
Debt/Equity Ratio	27.3%

How did BHIC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/29 14:45
End of Day Share Price	2026/06/29 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioScience Health Innovations, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.